Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

Neural Regen Res. 2017 Jan;12(1):72-74. doi: 10.4103/1673-5374.198986.

Authors

Mark R Kelley¹, Jill C Fehrenbacher²

Affiliations

¹ Pediatric Oncology Research; Departments of Biochemistry & Molecular Biology and Pharmacology & Toxicology; HB Wells Center for Pediatric Research; Basic Science Research, Indiana University Simon Cancer Center, Indianapolis, IN, USA.
² Department of Pharmacology and Toxicology; Stark Neuroscience Research Institute; Department of Anesthesiology, Indiana University School of Medicine, Indianapolis, IN, USA.

No abstract available

Grants and funding

R01 CA205166/CA/NCI NIH HHS/United States